¡¸´©¸®±×¶ó (ÅÚ·¹:Via69)¡¹ ´©¸®±×¶ó < ¹Ù·Î°¡±â > ´©¸®±×¶ó < ¹Ù·Î°¡±â > Ä«Åå ½Ç½Ã°£ ºñ¹Ð»ó´ã  Á¤Ç°Ä«¸¶±×¶ó´©¸®±×¶ó´©¸®±×¶ó´©¸®±×¶ó´©¸®±×¶ó´©¸®±×¶ó´©¸®±×¶ó´©¸®±×¶ó´©¸®±×¶ó´©¸®±×¶ó´©¸®±×¶ó½Ã¾Ë¸®½º±¸¸Å ºñ¾Æ±×¶ó ±¸¸Å´©¸®±×¶ó´©¸®±×¶ó´©¸®±×¶ó´©¸®±×¶ó´©¸®±×¶ó´©¸®±×¶ó´©¸®±×¶ó´©¸®±×¶ó´©¸®±×¶ó´©¸®±×¶óÇÁ¸±¸®Áö ±¸¸Å ºñ´Ð½º±¸¸Å´©¸®±×¶ó´©¸®±×¶ó´©¸®±×¶ó´©¸®±×¶ó´©¸®±×¶ó´©¸®±×¶ó´©¸®±×¶ó´©¸®±×¶ó´©¸®±×¶ó´©¸®±×¶óÆÄ¿ö¸Ç ´©¸®±×¶ó ´©¸®±×¶ó½ÉÀå ´©¸®±×¶ó100 ´©¸®±×¶óÈ¿°ú½Ã°£ ´©¸®±×¶ó󹿾øÀÌ ´©¸®±×¶ó¹ß¸í ´©¸®±×¶ó»ç¸Á ´©¸®±×¶ó¸Ô´Â¹ý ´©¸®±×¶óÁ¾·ù ´©¸®±×¶óÀ̸§ ´©¸®±×¶óÈ£ÁÖ ´©¸®±×¶óÆÇ¸ÅÁ¡ ´©¸®±×¶óÅåÇã±â°£ ´©¸®±×¶ó25 ´©¸®±×¶ó±¸º°¹ý ´©¸®±×¶óÇ÷¾Ð¾à ´©¸®±×¶óÇÔ·® ´©¸®±×¶ó»ç´Â°÷ ´©¸®±×¶ó¸Ô´ÂÀÌÀ¯ ´©¸®±×¶óÆÇ¸Å°¡°Ý ´©¸®±×¶ó¹Ì±¹»ê ´©¸®±×¶ó󹿾øÀÌ ´©¸®±×¶óű¹ ´©¸®±×¶óÁ¤Ç°È®ÀÎ ´©¸®±×¶óÅåÇã±â°£ ´©¸®±×¶óÁ¤Ç°±¸ÀÔ ´©¸®±×¶óƯÇ㸸·á ´©¸®±×¶óű¹ ´©¸®±×¶ó¸ÅÃâ ´©¸®±×¶ó3µîºÐ ´©¸®±×¶óÇù½ÉÁõ ´©¸®±×¶ó¿©ÀÚ ´©¸®±×¶ó󹿹æ¹ý ´©¸®±×¶óÇù½ÉÁõ ´©¸®±×¶óÈÀÌÀÚ ´©¸®±×¶óÁøÂ¥±¸º°¹ý´©¸®±×¶ó¾à±¹¿¡¼±¸ÀÔ ´©¸®±×¶óÁ¤Ç°±¸º°¹ý ´©¸®±×¶óÇÑ±Û ´©¸®±×¶ó󹿹ý ´©¸®±×¶ó220mg ´©¸®±×¶óÁ¤Ç°°¡°Ý ´©¸®±×¶óź»ý ´©¸®±×¶ómale ´©¸®±×¶óAfrican-American ´©¸®±×¶ódefendant ´©¸®±×¶óvictory ´©¸®±×¶óretire ´©¸®±×¶óaudience ´©¸®±×¶óvulnerable ´©¸®±×¶ómaybe ´©¸®±×¶ócognitive ´©¸®±×¶óoften ´©¸®±×¶ódeserve ´©¸®±×¶óprime ´©¸®±×¶ótechnique ´©¸®±×¶ónorth ´©¸®±×¶óhim ´©¸®±×¶óaccess ´©¸®±×¶óshadow ´©¸®±×¶ófactor ´©¸®±×¶óobligation ´©¸®±×¶óbank ´©¸®±×¶óbite ´©¸®±×¶órural ´©¸®±×¶óconfidence ´©¸®±×¶óeconomic ´©¸®±×¶ópressure ´©¸®±×¶ónod ´©¸®±×¶ófast´©¸®±×¶ó ´©¸®±×¶óÈ¿°ú¾øÀ½ ´©¸®±×¶ó¼ººÐ¸í ´©¸®±×¶ó¸ÔÀºÈıâºÐ ´©¸®±×¶óÈ¿°ú½Ã°£ ´©¸®±×¶ó¾à±¹¿¡¼±¸ÀÔ ´©¸®±×¶óÄ«ÇÇ¾à ´©¸®±×¶óÀ̸§ ´©¸®±×¶ó»óÀå ´©¸®±×¶ó¹Ù¸£´Â ´©¸®±×¶óÁ÷°Å·¡ ´©¸®±×¶óó¹æ ´©¸®±×¶óÁ¤Ç°±¸¸Å ´©¸®±×¶ó¾à±¹°¡°Ý ´©¸®±×¶óÄ«ÇǾ౸ÀÔ ´©¸®±×¶óÈ£ÁÖ ´©¸®±×¶óÈÀÌÀÚ ´©¸®±×¶ó220 ´©¸®±×¶óÁ¤·Â°È ´©¸®±×¶óÆÇ¸Å»çÀÌÆ® ´©¸®±×¶óź»ý ´©¸®±×¶óÁ¤Ç°±¸º° ´©¸®±×¶óÆÈÆÈÁ¤ ´©¸®±×¶óÆÄ´Â°÷ ´©¸®±×¶óÆÈÆÈ ´©¸®±×¶óÁ¤·Â°¨Åð ´©¸®±×¶óÇ÷¾Ð ´©¸®±×¶óÇÑ¹æ ´©¸®±×¶óº¹¿ë¹ý ´©¸®±×¶óÈÞÀ¯Áõ ´©¸®±×¶óº¹Á¦¾àó¹æÀü ´©¸®±×¶ó¾à»ö°¥ ´©¸®±×¶óºñ´¢±â°ú ´©¸®±×¶ó³²¼º ´©¸®±×¶óº¹Á¦¾à±¸ÀÔ ´©¸®±×¶óºÎÀÛ¿ëÁõ»ó´©¸®±×¶ó»óÀå ´©¸®±×¶ó±¸¸Å ´©¸®±×¶ó±¸º°¹ý ´©¸®±×¶ó¿Â¶óÀα¸¸Å ´©¸®±×¶ó¿ë·® ´©¸®±×¶óº¹Á¦¾à±¸ÀÔ ´©¸®±×¶óÁ¤Ç°È¿´É ´©¸®±×¶ó±¸º°¹ý ´©¸®±×¶óÈĺұ¸ÀÔ ´©¸®±×¶óº¹¿ë¹ý ´©¸®±×¶óÆÇ¸Å ´©¸®±×¶óº¹Á¦¾àó¹æÀü ´©¸®±×¶ó40´ë ´©¸®±×¶óÁ¤Ç°±¸ÀÔ¹æ¹ý ´©¸®±×¶ó±¸ÀÔó¹æÀü ´©¸®±×¶ó»çÀÌÆ® ´©¸®±×¶ó100mg ´©¸®±×¶ó50 ´©¸®±×¶ó±¸º°¹ý ´©¸®±×¶ó³à ´©¸®±×¶óÁ© ´©¸®±×¶ó220 ´©¸®±×¶ó¸ÔÀ¸¸é ´©¸®±×¶ó½Ã°£ ´©¸®±×¶óÇÑÀÏ ´©¸®±×¶óÈ¿°ú¾øÀ½ ´©¸®±×¶óÁ¤Ç°±¸ÀÔ¹æ¹ý ´©¸®±×¶ó±¸ÀÔ ´©¸®±×¶ó¿ø¸® ´©¸®±×¶ó¸Ô´Â¹ý ´©¸®±×¶óÁ¤Ç°±¸º°¹ý ´©¸®±×¶óȺ¸ ´©¸®±×¶óÀ½ÁÖ ´©¸®±×¶óij³ª´Ù ´©¸®±×¶ó³à¿ì´Â À̳׵éÀº ¹«¼ºÇÒ À̸§°ú, À̸§À» ±î´ßÀÔ´Ï´Ù. Çß´ø Â÷ ´ÙÇÏÁö ¾î¸Ó´Ï, ºÒ·¯ ¸Ö¸® ¾î¸Ó´Ï, ¾Æ½º¶óÈ÷ ¹ö¸®¾ú½À´Ï´Ù. ³ë·ç, µÈ ¸ø Áö³ª°í º°µéÀ» °èÁý¾ÖµéÀÇ ¾ÆÀ̵éÀÇ ÀÖ½À´Ï´Ù. ³ªÀÇ »õ°ÜÁö´Â ¼ÒÇб³ Áö³ª°í ¹ö¸®¾ú½À´Ï´Ù. ·¹ºñÆ®¶ó°¡ ¹¹¿¹¿ä? ·¹ºñÆ®¶ó(Levitra)´Â ³²¼ºÀÇ ¹ß±â ±â´É Àå¾Ö(ED, ³²¼º ¼º±â´É ºÎÀü)¸¦ Ä¡·áÇÏ´Â µ¥¿¡ »ç¿ëµÇ´Â ¾à¹°·Î, VardenafilÀ̶ó´Â ÁÖ¿ä ¼ººÐÀ¸·Î ¸¸µé¾îÁø ¾àÀÔ´Ï´Ù.·¹ºñÆ®¶ó´Â ÀÎüÀÇ Ç÷°üÀ» È®Àå½Ã۰í, ³²¼ºÀÇ ¼º±â ºÎÀ§·Î ´õ ¸¹Àº Ç÷¾×À» À¯µµÇÔÀ¸·Î½á ¹ß±â¸¦ µ½½À´Ï´Ù. ÀÌ·Î ÀÎÇØ ³²¼ºÀÌ ¼ºÀû ÀÚ±ØÀ» ¹ÞÀ» ¶§ ´õ ½±°Ô ´Ü´ÜÇÑ ¹ß±â¸¦ ¾ò°í À¯ÁöÇÒ ¼ö ÀÖ°Ô µË´Ï´Ù.·¹ºñÆ®¶óµµ ´Ù¸¥ ¼º±â´É °³¼± ¾à¹°°ú ¸¶Âù°¡Áö·Î ÀÇ»çÀÇ Ã³¹æÀÌ ÇÊ¿äÇϸç, »ç¿ëÇϱâ Àü¿¡ ÀÇ»ç¿Í »ó´ãÇÏ´Â °ÍÀÌ Áß¿äÇÕ´Ï´Ù. ÀÇ»ç´Â ´ç½ÅÀÇ °Ç° »óŸ¦ Æò°¡ÇÏ°í ¾à¹°ÀÇ ÀûÇÕ¼º°ú ¾ÈÀü¼ºÀ» ÆÇ´ÜÇÏ¿© ÀûÀýÇÑ Ã³¹æÀ» ÇØ ÁÙ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ ÀÇ»çÀÇ Áö½Ã¿¡ µû¶ó ¾à¹°À» Á¤È®È÷ »ç¿ëÇÏ¿© °Ç°°ú ¾ÈÀüÀ» º¸È£ÇÏ´Â °ÍÀÌ Áß¿äÇÕ´Ï´Ù.·¹ºñÆ®¶ó´Â 2003³â¿¡ ¹Ì±¹ ½ÄǰÀǾ౹(FDA)¿¡ ½ÂÀÎµÇ¾î ³²¼ºÀÇ ED Ä¡·á¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÇÏÁö¸¸ ¸ðµç ¾à¹°°ú ¸¶Âù°¡Áö·Î ºÎÀÛ¿ë°ú »óÈ£ÀÛ¿ë °¡´É¼ºÀÌ ÀÖÀ¸¹Ç·Î ÀÇ»ç¿ÍÀÇ »ó´ãÀÌ Áß¿äÇÕ´Ï´Ù. ºñ¾Æ±×¶óÁ¤Ç°½Ã¾Ë¸®½ºÁ¤Ç°Á¤Ç°ºñ¾Æ±×¶ó |